Cargando…

Genetic testing in pediatric endocrine pathology

In genetic endocrine diseases, genetic testing is necessary for a precise diagnosis, which will provide a better knowledge of the evolution and prognosis and also indicate the adequate therapy, targeting the precise etiopathogenesis of the disease. Genetic testing in endocrinology is often based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Miclea, Diana, Alkhzouz, Camelia, Bucerzan, Simona, Grigorescu-Sido, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411822/
https://www.ncbi.nlm.nih.gov/pubmed/34527901
http://dx.doi.org/10.15386/mpr-2220
_version_ 1783747353464799232
author Miclea, Diana
Alkhzouz, Camelia
Bucerzan, Simona
Grigorescu-Sido, Paula
author_facet Miclea, Diana
Alkhzouz, Camelia
Bucerzan, Simona
Grigorescu-Sido, Paula
author_sort Miclea, Diana
collection PubMed
description In genetic endocrine diseases, genetic testing is necessary for a precise diagnosis, which will provide a better knowledge of the evolution and prognosis and also indicate the adequate therapy, targeting the precise etiopathogenesis of the disease. Genetic testing in endocrinology is often based on classical cytogenetic techniques, molecular cytogenetic analysis or molecular biology techniques. Genetic testing in disorders of sex development includes the karyotype and SRY gene analysis and depending on the presence of associated clinical signs and on the observations at paraclinical examination, these tests will be followed by chromosomal array techniques and NGS sequencing. In short stature, the decision to perform a genetic test is taken depending on clinical, paraclinical and imaging signs. In case of a short stature associated with a low weight/length for gestational age, genetic testing is proposed to evaluate a Russell-Silver syndrome or if the short stature is associated with other clinical signs (e.g. intellectual disability), chromosomal analysis by microarray is proposed. If the short stature is disproportionate, it is indicated to perform a next generation sequencing (NGS) of a panel of genes involved in skeletal dysplasia. If an endocrine cause for short stature is observed at the hormonal evaluation, it is indicated to test a panel of genes involved in these pathways. In genetic obesity, depending on clinical signs associated to obesity, it will be a more targeted genetic testing. If obesity is associated with intellectual disability or other nonspecific neurological changes, a chromosomal analysis by microarray will be indicated. If monogenic obesity is suspected, NGS testing will be indicated (as genes panel or whole exome or genome analysis). Genetic testing in endocrine diseases brings an etiological diagnosis, but a favorable cost-benefit ratio derives from an adequate indication of these tests, generally proposed in expert centers for rare endocrine diseases.
format Online
Article
Text
id pubmed-8411822
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-84118222021-09-14 Genetic testing in pediatric endocrine pathology Miclea, Diana Alkhzouz, Camelia Bucerzan, Simona Grigorescu-Sido, Paula Med Pharm Rep Articles In genetic endocrine diseases, genetic testing is necessary for a precise diagnosis, which will provide a better knowledge of the evolution and prognosis and also indicate the adequate therapy, targeting the precise etiopathogenesis of the disease. Genetic testing in endocrinology is often based on classical cytogenetic techniques, molecular cytogenetic analysis or molecular biology techniques. Genetic testing in disorders of sex development includes the karyotype and SRY gene analysis and depending on the presence of associated clinical signs and on the observations at paraclinical examination, these tests will be followed by chromosomal array techniques and NGS sequencing. In short stature, the decision to perform a genetic test is taken depending on clinical, paraclinical and imaging signs. In case of a short stature associated with a low weight/length for gestational age, genetic testing is proposed to evaluate a Russell-Silver syndrome or if the short stature is associated with other clinical signs (e.g. intellectual disability), chromosomal analysis by microarray is proposed. If the short stature is disproportionate, it is indicated to perform a next generation sequencing (NGS) of a panel of genes involved in skeletal dysplasia. If an endocrine cause for short stature is observed at the hormonal evaluation, it is indicated to test a panel of genes involved in these pathways. In genetic obesity, depending on clinical signs associated to obesity, it will be a more targeted genetic testing. If obesity is associated with intellectual disability or other nonspecific neurological changes, a chromosomal analysis by microarray will be indicated. If monogenic obesity is suspected, NGS testing will be indicated (as genes panel or whole exome or genome analysis). Genetic testing in endocrine diseases brings an etiological diagnosis, but a favorable cost-benefit ratio derives from an adequate indication of these tests, generally proposed in expert centers for rare endocrine diseases. Iuliu Hatieganu University of Medicine and Pharmacy 2021-08 2021-08-10 /pmc/articles/PMC8411822/ /pubmed/34527901 http://dx.doi.org/10.15386/mpr-2220 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Articles
Miclea, Diana
Alkhzouz, Camelia
Bucerzan, Simona
Grigorescu-Sido, Paula
Genetic testing in pediatric endocrine pathology
title Genetic testing in pediatric endocrine pathology
title_full Genetic testing in pediatric endocrine pathology
title_fullStr Genetic testing in pediatric endocrine pathology
title_full_unstemmed Genetic testing in pediatric endocrine pathology
title_short Genetic testing in pediatric endocrine pathology
title_sort genetic testing in pediatric endocrine pathology
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411822/
https://www.ncbi.nlm.nih.gov/pubmed/34527901
http://dx.doi.org/10.15386/mpr-2220
work_keys_str_mv AT micleadiana genetictestinginpediatricendocrinepathology
AT alkhzouzcamelia genetictestinginpediatricendocrinepathology
AT bucerzansimona genetictestinginpediatricendocrinepathology
AT grigorescusidopaula genetictestinginpediatricendocrinepathology